for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Hutchison China MediTech Says Co, Beigene Enter Into Clinical Collaboration

May 26 (Reuters) - Hutchison China MediTech Ltd:

* CHI-MED AND BEIGENE ENTER CLINICAL COLLABORATION

* CHI-MED, BEIGENE ENTER INTO CLINICAL COLLABORATION TO EVALUATE COMBINATIONS OF SURUFATINIB, FRUQUINTINIB WITH TISLELIZUMAB

* CHI-MED AND BEIGENE ENTER CLINICAL COLLABORATION TO EXPLORE MULTIPLE SOLID TUMOR CANCER INDICATIONS

* COLLABORATION WITH BEIGENE, INITIAL DEVELOPMENT FOCUSED ON MULTI-COHORT TRIALS IN U.S., EUROPE, CHINA AND AUSTRALIA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up